Cancer Biomarkers


Malignant growth biomarkers also known as cancer biomarkers (CB) are bimolecular created either by the tumor cells or by different cells of the body in light of the tumor, and CB could be utilized as screening/early location instrument of disease, demonstrative, prognostic, or indicator for the general result of a patient. Besides, malignancy biomarkers may distinguish subpopulations of patients who are well on the way to react to a given treatment. Biomarkers can be qualities, quality items, explicit cells, particles, catalysts, or chemicals which can be identified in blood, pee, tissues, or other body liquid.



 


  • Cell Lung Cancer Adhesion Molecules
  • Genetic Mutations
  • Gene Silencing
  • Chromosomal Changes
  • Genomic Instability

Related Conference of Cancer Biomarkers

March 18-19, 2024

5th Global Summit on Oncology and Hematology

Zurich, Switzerland
June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France

Cancer Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in